Michael J. Rock, MD Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Dr. Michael Rock completed a pediatric pulmonology fellowship at the University of Wisconsin-Madison from 1986 to 1989. During his fellowship, he became interested in the care of children with cystic fibrosis (CF) and became particularly involved with the Wisconsin Neonatal Screening Study. He was on the faculty of the University of Tennessee-Memphis for five and one-half years before returning to the University of Wisconsin in 1995. He was promoted to associate professor in 1997 and full professor in 2002.
In his current position at the University of Wisconsin, he is division head of pediatric pulmonology, director of the Cystic Fibrosis Center, director of the pediatric pulmonology fellowship and he chairs the CF Newborn Screening Advisory Group (Maternal and Child Health Section, State of Wisconsin). He served on the Cystic Fibrosis Foundation Center Committee from 2000-2004. This committee, consisting of CF Center Directors, is charged with formulating policy decisions for the care of CF patients in CF Centers and oversees centers through site visits.
UW Health Clinics
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
UW School of Medicine and Public Health
|Department of Pediatrics|
Professional Certifications and Education
University of Wisconsin Hospital and Clinics, Madison, WI
Oklahoma Children's Memorial Hospital
Oklahoma Children's Memorial Hospital
University of Oklahoma, Oklahoma City, 1983
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
Dr. Rock’s research interests are cystic fibrosis (CF) newborn screening and clinical trials of new drug therapies for cystic fibrosis.
Tluczek A Becker T Grieve A Laxova A Rock MJ Gershan WM Green CG Farrell PM .
Health-related quality of life in children and adolescents with cystic fibrosis: convergent validity with parent-reports and objective measures of pulmonary health. J Dev Behav Pediatr. 2013 May;34(4):252-61
[PubMed ID: 23669872]
Li Z Sanders DB Rock MJ Kosorok MR Collins J Green CG Brody AS Farrell PM .
Regional differences in the evolution of lung disease in children with cystic fibrosis. Pediatr Pulmonol. 2012 Jul;47(7):635-40
[PubMed ID: 22162514]
Sanders DB Li Z Rock MJ Brody AS Farrell PM .
The sensitivity of lung disease surrogates in detecting chest CT abnormalities in children with cystic fibrosis. Pediatr Pulmonol. 2012 Jun;47(6):567-73
[PubMed ID: 22170734]
Sanders DB Lai HJ Rock MJ Farrell PM .
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies. J Cyst Fibros. 2012 Mar;11(2):150-3
[PubMed ID: 22104951]
Rock MJ Levy H Zaleski C Farrell PM .
Factors accounting for a missed diagnosis of cystic fibrosis after newborn screening. Pediatr Pulmonol. 2011 Dec;46(12):1166-74
[PubMed ID: 22081556]
Tluczek A Becker T Laxova A Grieve A Racine Gilles CN Rock MJ Gershan WM Green CG Farrell PM .
Relationships among health-related quality of life, pulmonary health, and newborn screening for cystic fibrosis. Chest. 2011 Jul;140(1):170-7
[PubMed ID: 21106659]
Baker MW Groose M Hoffman G Rock M Levy H Farrell PM .
Optimal DNA tier for the IRT/DNA algorithm determined by CFTR mutation results over 14 years of newborn screening. J Cyst Fibros. 2011 Jul;10(4):278-81
[PubMed ID: 21388895]
Jadin SA Wu GS Zhang Z Shoff SM Tippets BM Farrell PM Miller T Rock MJ Levy H Lai HJ .
Growth and pulmonary outcomes during the first 2 y of life of breastfed and formula-fed infants diagnosed with cystic fibrosis through the Wisconsin Routine Newborn Screening Program. Am J Clin Nutr. 2011 May;93(5):1038-47
[PubMed ID: 21430114]
Rock MJ Sharp JK .
Cystic fibrosis and CRMS screening: what the primary care pediatrician should know. Pediatr Ann. 2010 Dec;39(12):759-68
[PubMed ID: 21162484]
Farrell PM Collins J Broderick LS Rock MJ Li Z Kosorok MR Laxova A Gershan WM Brody AS .
Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis. Radiology. 2009 Aug;252(2):534-43
[PubMed ID: 19703887]
Kloosterboer M Hoffman G Rock M Gershan W Laxova A Li Z Farrell PM .
Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen. Pediatrics. 2009 Feb;123(2):e338-46
[PubMed ID: 19171585]
Varness T Seffrood EE Connor EL Rock MJ Allen DB .
Oxandrolone Improves Height Velocity and BMI in Patients with Cystic Fibrosis. Int J Pediatr Endocrinol. 2009;2009:826895
[PubMed ID: 20145725]
Farrell PM Rosenstein BJ White TB Accurso FJ Castellani C Cutting GR Durie PR Legrys VA Massie J Parad RB Rock MJ Campbell PW 3rd .
Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008 Aug;153(2):S4-S14
[PubMed ID: 18639722]
Rock MJ .
Newborn screening for cystic fibrosis. Clin Chest Med. 2007 Jun;28(2):297-305
[PubMed ID: 17467549]
Tluczek A Koscik RL Modaff P Pfeil D Rock MJ Farrell PM Lifchez C Freeman ME Gershan W Zaleski C Sullivan B .
Newborn screening for cystic fibrosis: parents' preferences regarding counseling at the time of infants' sweat test. J Genet Couns. 2006 Aug;15(4):277-91
[PubMed ID: 16865559]
Rock MJ Hoffman G Laessig RH Kopish GJ Litsheim TJ Farrell PM .
Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing. J Pediatr. 2005 Sep;147(3 Suppl):S73-7
[PubMed ID: 16202788]
Koscik RL Douglas JA Zaremba K Rock MJ Splaingard ML Laxova A Farrell PM .
Quality of life of children with cystic fibrosis. J Pediatr. 2005 Sep;147(3 Suppl):S64-8
[PubMed ID: 16202786]
Koscik RL Lai HJ Laxova A Zaremba KM Kosorok MR Douglas JA Rock MJ Splaingard ML Farrell PM .
Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening. J Pediatr. 2005 Sep;147(3 Suppl):S51-6
[PubMed ID: 16202783]
Farrell PM Lai HJ Li Z Kosorok MR Laxova A Green CG Collins J Hoffman G Laessig R Rock MJ Splaingard ML .
Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough! J Pediatr. 2005 Sep;147(3 Suppl):S30-6
[PubMed ID: 16202779]
Tluczek A Koscik RL Farrell PM Rock MJ .
Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment. Pediatrics. 2005 Jun;115(6):1692-703
[PubMed ID: 15930234]
Li Z Kosorok MR Farrell PM Laxova A West SE Green CG Collins J Rock MJ Splaingard ML .
Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA. 2005 Feb 2;293(5):581-8
[PubMed ID: 15687313]